Mary F. McNaughton Collins, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatitis | 23 | 2010 | 102 | 2.550 |
Why?
|
Pelvic Pain | 12 | 2010 | 298 | 1.240 |
Why?
|
Prostate-Specific Antigen | 12 | 2011 | 2469 | 0.770 |
Why?
|
Mass Screening | 7 | 2014 | 5429 | 0.530 |
Why?
|
Prostatic Neoplasms | 16 | 2011 | 11122 | 0.520 |
Why?
|
Decision Making | 3 | 2014 | 3929 | 0.380 |
Why?
|
Prostatic Hyperplasia | 3 | 2007 | 521 | 0.290 |
Why?
|
Patient Participation | 3 | 2014 | 1445 | 0.290 |
Why?
|
Prostate | 2 | 2006 | 1773 | 0.280 |
Why?
|
Physicians, Family | 1 | 2009 | 350 | 0.280 |
Why?
|
Domestic Violence | 1 | 2007 | 182 | 0.260 |
Why?
|
Urination Disorders | 2 | 2006 | 238 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2014 | 4016 | 0.250 |
Why?
|
Health Care Surveys | 2 | 2014 | 2426 | 0.240 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 7391 | 0.230 |
Why?
|
Sex Offenses | 1 | 2007 | 352 | 0.210 |
Why?
|
Medication Adherence | 1 | 2014 | 2176 | 0.210 |
Why?
|
Quality of Life | 11 | 2008 | 13367 | 0.210 |
Why?
|
Chronic Disease | 19 | 2010 | 9319 | 0.210 |
Why?
|
Urology | 3 | 2002 | 400 | 0.210 |
Why?
|
Adrenergic alpha-Antagonists | 3 | 2008 | 174 | 0.200 |
Why?
|
Early Detection of Cancer | 1 | 2014 | 3201 | 0.170 |
Why?
|
False Positive Reactions | 3 | 2009 | 957 | 0.170 |
Why?
|
Cystitis, Interstitial | 3 | 2010 | 66 | 0.170 |
Why?
|
Cost of Illness | 3 | 2007 | 1937 | 0.170 |
Why?
|
Antimetabolites | 1 | 2000 | 129 | 0.160 |
Why?
|
Radiation Oncology | 2 | 2002 | 563 | 0.160 |
Why?
|
Allopurinol | 1 | 2000 | 198 | 0.150 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8002 | 0.150 |
Why?
|
Male Urogenital Diseases | 2 | 2009 | 48 | 0.150 |
Why?
|
Family Practice | 1 | 2000 | 512 | 0.140 |
Why?
|
Health Status Indicators | 3 | 2005 | 970 | 0.110 |
Why?
|
Primary Health Care | 3 | 2011 | 4687 | 0.110 |
Why?
|
Male | 41 | 2014 | 360846 | 0.110 |
Why?
|
Orchiectomy | 2 | 2008 | 463 | 0.110 |
Why?
|
Androgen Antagonists | 3 | 2008 | 1410 | 0.090 |
Why?
|
Middle Aged | 27 | 2014 | 220921 | 0.090 |
Why?
|
Aged | 22 | 2014 | 169310 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2004 | 3462 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2014 | 590 | 0.090 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2009 | 793 | 0.080 |
Why?
|
Female Urogenital Diseases | 1 | 2009 | 57 | 0.080 |
Why?
|
American Cancer Society | 1 | 2009 | 69 | 0.080 |
Why?
|
Biopsy | 3 | 2006 | 6766 | 0.080 |
Why?
|
Adult | 22 | 2014 | 221210 | 0.080 |
Why?
|
Humans | 44 | 2014 | 761596 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2014 | 58984 | 0.070 |
Why?
|
Prostatectomy | 4 | 2005 | 1824 | 0.070 |
Why?
|
Knowledge | 1 | 2009 | 177 | 0.070 |
Why?
|
Prescription Drugs | 1 | 2014 | 631 | 0.070 |
Why?
|
Advisory Committees | 1 | 2011 | 787 | 0.070 |
Why?
|
Syndrome | 3 | 2009 | 3267 | 0.070 |
Why?
|
Preventive Health Services | 1 | 2011 | 567 | 0.070 |
Why?
|
Neoplasms | 2 | 2014 | 22173 | 0.070 |
Why?
|
United States | 16 | 2011 | 72340 | 0.070 |
Why?
|
Translations | 1 | 2005 | 81 | 0.060 |
Why?
|
Health Services Research | 2 | 2004 | 1812 | 0.060 |
Why?
|
Physician-Patient Relations | 3 | 2014 | 3251 | 0.060 |
Why?
|
Child Abuse, Sexual | 1 | 2007 | 403 | 0.060 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1141 | 0.060 |
Why?
|
Urodynamics | 1 | 2005 | 346 | 0.060 |
Why?
|
Self Disclosure | 1 | 2004 | 249 | 0.060 |
Why?
|
Analgesics | 1 | 2010 | 1070 | 0.050 |
Why?
|
Urinalysis | 1 | 2005 | 368 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 2007 | 489 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2004 | 312 | 0.050 |
Why?
|
Quinazolines | 1 | 2008 | 1371 | 0.050 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2008 | 1148 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3688 | 0.050 |
Why?
|
Rest | 1 | 2006 | 918 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2009 | 5493 | 0.050 |
Why?
|
Florida | 1 | 2002 | 431 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2005 | 909 | 0.040 |
Why?
|
Attitude to Health | 2 | 2006 | 2025 | 0.040 |
Why?
|
Office Visits | 2 | 2004 | 595 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 186 | 0.040 |
Why?
|
Physical Examination | 1 | 2005 | 1255 | 0.040 |
Why?
|
Radiotherapy, Conformal | 1 | 2002 | 548 | 0.040 |
Why?
|
Pain Measurement | 2 | 2007 | 3551 | 0.040 |
Why?
|
Adaptation, Psychological | 2 | 2007 | 2629 | 0.040 |
Why?
|
Prospective Studies | 6 | 2007 | 54423 | 0.040 |
Why?
|
Canada | 3 | 2010 | 2122 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3415 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 6180 | 0.040 |
Why?
|
Boston | 2 | 2007 | 9327 | 0.040 |
Why?
|
Brachytherapy | 2 | 2002 | 1223 | 0.040 |
Why?
|
Palpation | 1 | 1997 | 166 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2004 | 983 | 0.040 |
Why?
|
Societies, Medical | 1 | 2009 | 3905 | 0.030 |
Why?
|
Prevalence | 3 | 2007 | 15733 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2008 | 7406 | 0.030 |
Why?
|
Geriatrics | 1 | 2000 | 388 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3713 | 0.030 |
Why?
|
Sulfonamides | 1 | 2004 | 1979 | 0.030 |
Why?
|
Severity of Illness Index | 4 | 2009 | 15843 | 0.030 |
Why?
|
Health Expenditures | 1 | 2007 | 2366 | 0.030 |
Why?
|
Data Collection | 2 | 2002 | 3322 | 0.030 |
Why?
|
Pain | 1 | 2009 | 5073 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2002 | 1520 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2006 | 3728 | 0.030 |
Why?
|
Health Status | 2 | 2004 | 4077 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2004 | 20100 | 0.030 |
Why?
|
Cohort Studies | 5 | 2007 | 41495 | 0.030 |
Why?
|
Logistic Models | 1 | 2007 | 13255 | 0.030 |
Why?
|
Internal Medicine | 1 | 2000 | 1051 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5971 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2002 | 3600 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2002 | 6815 | 0.020 |
Why?
|
Ultrasonic Therapy | 1 | 1994 | 215 | 0.020 |
Why?
|
Epidemiologic Methods | 2 | 2008 | 1336 | 0.020 |
Why?
|
Incidence | 2 | 2007 | 21355 | 0.020 |
Why?
|
Treatment Failure | 2 | 2008 | 2643 | 0.020 |
Why?
|
Health Care Costs | 1 | 2004 | 3242 | 0.020 |
Why?
|
Female | 6 | 2014 | 392705 | 0.020 |
Why?
|
Hyperthermia, Induced | 1 | 1994 | 417 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 64685 | 0.020 |
Why?
|
Research | 1 | 1997 | 1982 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 564 | 0.020 |
Why?
|
Disease Progression | 1 | 2005 | 13510 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2002 | 3889 | 0.020 |
Why?
|
Health Surveys | 2 | 2009 | 4061 | 0.020 |
Why?
|
Social Support | 2 | 2007 | 2172 | 0.020 |
Why?
|
Prognosis | 2 | 2008 | 29629 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14665 | 0.020 |
Why?
|
Urethritis | 1 | 2005 | 24 | 0.020 |
Why?
|
Patient Selection | 1 | 1997 | 4244 | 0.020 |
Why?
|
Direct Service Costs | 1 | 2004 | 59 | 0.010 |
Why?
|
Anger | 1 | 2006 | 406 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2010 | 12341 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2000 | 10212 | 0.010 |
Why?
|
Age Factors | 1 | 2000 | 18399 | 0.010 |
Why?
|
Patients | 1 | 2009 | 907 | 0.010 |
Why?
|
Absenteeism | 1 | 2004 | 247 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 635 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2879 | 0.010 |
Why?
|
Drug Utilization | 1 | 2008 | 1188 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1994 | 3575 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 2008 | 802 | 0.010 |
Why?
|
Health Resources | 1 | 2007 | 935 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2707 | 0.010 |
Why?
|
Placebos | 1 | 2004 | 1667 | 0.010 |
Why?
|
Psychometrics | 1 | 2009 | 3065 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2319 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2006 | 1836 | 0.010 |
Why?
|
Child | 1 | 2007 | 80158 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2000 | 26129 | 0.010 |
Why?
|
Risk Factors | 1 | 2005 | 74213 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4915 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2007 | 2775 | 0.010 |
Why?
|
Health Education | 1 | 2002 | 1052 | 0.010 |
Why?
|
Hospitalization | 2 | 2007 | 10721 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3206 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2005 | 1667 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6312 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12059 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11120 | 0.010 |
Why?
|
Mathematics | 1 | 1994 | 707 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 1994 | 490 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2006 | 4481 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8527 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 14033 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2007 | 7879 | 0.000 |
Why?
|
Kinetics | 1 | 1994 | 6374 | 0.000 |
Why?
|
Young Adult | 1 | 2008 | 59260 | 0.000 |
Why?
|
Risk Assessment | 1 | 2002 | 23996 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 15502 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 88326 | 0.000 |
Why?
|